Clinical Trials

Key Trials and Clinical Trial Resources

  • Canadian Clinical Trials Asset Map
    • Developed by the Canadian Clinical Trials Coordinating Centre, the Canadian Clinical Trials Asset Map (CCTAM) is the first pan-Canadian research inventory of investigators, clinical research sites, hospitals, institutions, research ethics boards (REBs) and other clinical research resources available across the country.
  • CIHR COVID-19 Resources: Clinical trials and research involving humans
    • Clinical trial resources for COVID19 developed by the Canadian Institute of Health Research (CIHR).
  • Solidarity
    • Solidarity is an international clinical trial to help find an effective treatment for COVID-19, launched by the World Health Organization and partners.
  • Solidarity II
    • Solidarity II is a global collaboration led by the World Health Organization that promotes the implementation of serological surveys of SARS-CoV-2.
  • Metadata Repository for Clinical Trials Objects
  • Trial Forge
    • The site provides material to assist in the design of clinical trials and research studies during COVID-19.
  • Capacity: Registry of COVID-19 patients
    • CAPACITY is an international registry of patients with COVID-19 established to address on the role of cardiovascular disease in COVID-19.
  • Randomised, Embedded, Multifactorial, Adaptive Platform
  • BC COVID-19 Clinical Trials Network
    • BC clinical trial community network with monthly meetings of 70 participants across the province.  This informal network engages over 120 members to enable increased communications, learning, and a coordinated approach through email, Slack and Twitter.
  • BC COVID-19 Resources
    • A listing of COVID-19 response activities and available resources in BC, Canada and internationally – specifically for clinical researchers.

Clinical Trials Registries – International

Clinical Trials Registries – National

Study Trackers

Drug Profiles

  • AdisInsight
    • AdisInsight provides profiles of drug development programs actively investigating treatments for Coronavirus and summaries of the clinical trials being conducted for those drugs.
  • COVID-19 Drug Evidence Initiative
    • Critical appraisal of clinical trial reports on the treatment of SARS-CoV-2 curated by the Pharmacy Department of the University of Toronto, Canada.